regadenoson .08 mg/mL

Regadenoson .08 mg/mL is an injectable solution used for medical imaging procedures. This pharmaceutical, manufactured by Baxter Healthcare Corporation, is designed to enhance diagnostic accuracy in certain cardiovascular assessments.

Regadenoson .08 mg/mL is primarily used in medical imaging to evaluate blood flow in the heart. This injectable solution is often administered intravenously to assist in diagnosing coronary artery disease. It works by temporarily increasing blood flow to the heart, which can help identify areas of reduced perfusion.

Common effects of regadenoson .08 mg/mL may include temporary increases in heart rate and blood pressure. Some individuals might experience flushing, headache, or dizziness. These effects are generally short-lived and subside quickly after administration.

Regadenoson .08 mg/mL should be used with caution in individuals with certain heart conditions or a history of seizures. It is important to follow medical guidelines and consult a healthcare provider before use. Always store the solution as directed to maintain its efficacy.

Regadenoson .08 mg/mL may interact with other medications, particularly those that affect heart rate or blood pressure. It is advisable to inform your healthcare provider about all medications you are taking before administration. Avoid combining it with stimulants or other cardiovascular drugs without professional advice.